Gemoscan Canada, Inc.
TSX VENTURE : GES
MUN : 1GE

Gemoscan Canada, Inc.

March 29, 2012 13:36 ET

Gemoscan Canada Announces Appointment of Senior Vice President Sales and Marketing

TORONTO, ONTARIO--(Marketwire - March 28, 2012) - Gemoscan Canada, Inc. ("Gemoscan" or the "Company") - (TSX VENTURE:GES) (MUN:1GE) is pleased to announce the appointment of Felice Fleisher as Senior Vice President Sales and Marketing. Ms. Fleisher reports to President and CEO, Brian Kalish.

Ms. Fleisher brings more than 20 years experience in both the U.S. and Canadian business and corporate environments with general management and hands on skills in all areas of business development including sales, marketing, analytics, planning, operations, supply chain, IT and systems oversight, ERP/transition planning, budgets, forecasting and government relations.

From 1990 - 2009, Ms. Fleisher held senior management positions at Paramount Home Entertainment Canada, including Senior Vice President and General Manager (2004-2009), Senior Vice President (1998-2003), Vice President Sales (1994-1997) and Executive Director Sales and Operations (1990-1993). During her tenure, Ms. Fleisher established the Canadian office from start-up quickly developing Paramount Home Entertainment to one of Canada's top grossing and most respected home entertainment studios. From 1986 to 1990, Ms. Fleisher held management positions at Paramount Pictures Corporation and Paramount Home Video including Director of Distribution Marketing and Regional Sales Manager.

Brian Kalish, President and CEO commented, "We are delighted to welcome Felice to the Gemoscan team and look forward to her contributions as we take the Company to the next level in building the HEMOCODE brand."

ABOUT GEMOSCAN CANADA, INC.

Founded in 2003, Gemoscan Canada, Inc. owns and markets the HEMOCODE Food Intolerance System, a personalized naturopathic nutritional program that promotes wellbeing. HEMOCODE™ uses patented technology and services to provide consultation and recommendations to simplify the management of food sensitivities. Gemoscan Canada, Inc. trades its shares on the Toronto Venture Exchange (TSX-V) under the symbol GES.

Forward-Looking Information

This news release contains certain "forward-looking information". All statements, other than statements of historical fact that address activities, events or developments that Gemoscan believes, expects or anticipates will or may occur in the future. These forward-looking statements reflect the current expectations or beliefs of Gemoscan based on information currently available to Gemoscan. Forward-looking statements are subject to a number of significant risks and uncertainties and other factors that may cause the actual results of Gemoscan to differ materially from those discussed in the forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on Gemoscan. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Gemoscan disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Although Gemoscan believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information